Clinical Trial Record

Return to Clinical Trials

Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer


2014-11


2015-05


2015-05


10

Study Overview

Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer

This pilot clinical trial studies a palliative care program in improving the quality of life of patients with newly diagnosed pancreatic cancer. Palliative care is care given to patients who have a serious or life-threatening disease, and focuses on managing disease symptoms, side effects of treatment or the disease, and improving patient quality of life. Studying a palliative care program used for other types of cancer may help doctors learn whether it can improve the quality of life of patients with pancreatic cancer.

PRIMARY OBJECTIVES: I. To pilot-test an interdisciplinary Palliative Care Planning Intervention (PCPI) in pancreatic cancer. Specifically, to describe patients' satisfaction with the timing, content, and delivery of the PCPI intervention. SECONDARY OBJECTIVES: I. To pilot-test all selected measures for the study, including measures for healthcare resource utilization, overall cost, and patient/family out of pocket expenses. II. The long-term objective of this pilot study is to conduct a larger PCPI intervention study for pancreatic cancer patients and evaluate its impact on quality of life (QOL), symptom intensity, healthcare resource utilization, and healthcare costs. OUTLINE: Patients receive a handbook titled "Supporting You During Cancer Treatment" with educational material on QOL issues. Patients undergo 2 education sessions on handbook material in-person or by telephone, with session 1 focusing on physical and social well-being issues and session 2 focusing on psychological and spiritual well-being issues. At the beginning of each session, patients select 3 priority topics from a list, and content is tailored to patient needs. After completion of study, patients are followed up at 1 and 2 months.

  • Stage IIA Pancreatic Cancer
  • Stage IIB Pancreatic Cancer
  • Stage III Pancreatic Cancer
  • Stage IV Pancreatic Cancer
  • PROCEDURE: Psychosocial Assessment and Care
  • OTHER: Palliative Therapy
  • OTHER: Quality-of-Life Assessment
  • OTHER: Questionnaire Administration
  • 14273
  • NCI-2014-02367 (REGISTRY Identifier) (REGISTRY: CTRP (Clinical Trial Reporting Program))
  • 14273 (OTHER Identifier) (OTHER: City of Hope Medical Center)
  • U24NR014637 (U.S. NIH Grant/Contract)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2014-12-02  

N/A  

2015-06-01  

2014-12-02  

N/A  

2015-06-03  

2014-12-04  

N/A  

2015-06  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Supportive Care


Allocation:
Na


Interventional Model:
Single Group


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: Supportive care (PCPI intervention)

Patients receive a handbook titled "Supporting You During Cancer Treatment" with educational material on QOL issues. Patients undergo 2 education sessions on handbook material in-person or by telephone, with session 1 focusing on physical and social well-

PROCEDURE: Psychosocial Assessment and Care

  • Undergo PCPI

OTHER: Palliative Therapy

  • Undergo PCPI

OTHER: Quality-of-Life Assessment

  • Undergo QOL assessment

OTHER: Questionnaire Administration

  • Undergo questionnaire administration
Primary Outcome MeasuresMeasure DescriptionTime Frame
Reasons for refusal to participateDescriptive statistics will be provided.Up to 2 months
Reasons for failure to complete studyDescriptive statistics will be provided.Up to 2 months
Attendance at two educational sessionsDescriptive statistics will be provided.Up to 2 months
Completion of interventionDescriptive statistics will be provided.Up to 2 months
Patient satisfaction with timing, content, and delivery of PCPIPresented through summary statistics of data from the patient satisfaction tool.Up to 2 months
Qualitative interview dataEach interview transcript will be initially reviewed to provide a glimpse of potential domains and targets. Content analysis will be conducted on the transcribed qualitative data. Transcripts will be assigned codes. Content analysis occurring through coding consisting of line-by-line analysis with themes identified will be initiated. The research team will independently analyze selected segments of the data to verify themes. Coding will be checked and validated by the principal investigator and research team.Up to 2 months
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Healthcare resource utilization, as measured by the Report of Healthcare Services FormData will be summarized using descriptive statistics. Established instruments will be scored according to standard instructions, and appropriate descriptive statistics computed.Up to 2 months
Overall cost, as measured by the Finances and Out of Pocket Costs ToolData will be summarized using descriptive statistics. Established instruments will be scored according to standard instructions, and appropriate descriptive statistics computed.Up to 2 months
Patient/family out of pocket expenses, as measured by the Finances and Out of Pocket Costs ToolData will be summarized using descriptive statistics. Established instruments will be scored according to standard instructions, and appropriate descriptive statistics computed.Up to 2 months

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
21 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Pathologically confirmed, new diagnosis of borderline resectable, locally advanced resectable/unresectable, or metastatic pancreatic cancer
  • Patients who are scheduled to receive treatments (neoadjuvant therapy, surgery, adjuvant therapy, or palliative chemotherapy) at City of Hope (COH)
  • All subjects must have the ability to understand and the willingness to provide informed consent

  • Exclusion Criteria:

  • Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • National Cancer Institute (NCI)
  • National Institute of Nursing Research (NINR)

  • PRINCIPAL_INVESTIGATOR: Virginia Sun, City of Hope Medical Center

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available